View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Daniel Ives ... (+2)
  • Daniel Ives
  • Steven Wahrhaftig

Navigating Choppy Waters Amid Difficult Backdrop; Initiate NEUTRAL

Key CatalystsReaccelerating growth across core verticalsExpanding its pipeline of 9-figure contracts; accelerate conversion of large-scale dealsNextGen program providing AI uplift to bottom-line estimatesM&A pipeline set to drive revenue upside; unsure of current pipeline of dealsCognizant is a

Advanced Micro Devices Inc: 1 director

A director at Advanced Micro Devices Inc sold 3,293 shares at 225.000USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

AMD to Report Fiscal First Quarter 2026 Financial Results

AMD to Report Fiscal First Quarter 2026 Financial Results SANTA CLARA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: AMD) announced today that it will report fiscal first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. Management will conduct a conference call to discuss these results at 5:00 p.m. ET / 2:00 p.m. PT. Interested parties are invited to listen to the webcast of the conference call via the AMD Investor Relations website . AMD also announced it will participate in the following event for the financial community: Jean Hu, executive vice p...

Antoine Legault ... (+2)
  • Antoine Legault
  • Matthew Bryson

Daily Views on Tech Headlines | Memory, INTC, SMCI, Quantum

Our conversations to date suggest (at least in the near-term) that the March news that certain SMCI employees had conspired to ship significant dollars of servers to China is not having a significant impact on operations. At the same time, we still see a probability that customers, suppliers, and/o

Pierre FerraguÊ
  • Pierre FerraguÊ

Anthropic/OpenAI ARR growth already covers 2026 AI capex?

Anthropic and OpenAI added ~$30bn of ARR over the past three months and are on track to add >$100bn this year. Click the link for our take and implications for the AI infra value chain.

Pierre FerraguÊ
  • Pierre FerraguÊ

Anthropic & OpenAI - How much further can frontier lab revenues accele...

Anthropic announced last night that its ARR has reached $30bn, up from $9bn at the end of 2025. In today's one-slider we analyze how much further frontier lab revenues can accelerate.

Michael Piccolo
  • Michael Piccolo

Daily Recap: GSAT/AMZN, CVS, TRMB, INTC/APO, WMG, VGNT/APTV, CWST, MKC...

CVS Health Corp. (CVS - $72.49)Omnicare Advances Court-Supervised Process; Stalking Horse Bidder Named; Chapter 11 Auction Set. Omnicare, a subsidiary of CVS, announced on April 1, 2026, it has entered into an asset purchase agreement with GenieRx Holdings LLC, a joint venture between private inves

Moody's Ratings says Intel's acquisition of Apollo's minority interest...

Announcement: Moody's Ratings says Intel's acquisition of Apollo's minority interest in Ireland JV is credit positive. Global Credit Research- 01 Apr 2026. New York, April 01, 2026-- Moody's Ratings said that Intel Corporation's plan to repurchase the 49% equity interest in its joint venture with Apollo, which owns and operates Fab 34 in Ireland, is credit positive for Intel.

Antoine Chkaiban
  • Antoine Chkaiban

Intel: is 35-40% Foundry gross margin ever achievable?

The gross margin of Intel Foundry is in negative territory today and were guided, back in 2024, to reach 35-40% in 2030. In today’s research we gather all what we know and can estimate about Intel and TSMC’s cost structures at the leading edge. From this baseline, we analyze the drivers of the current gap between the two, and assess how Intel could eventually achieve its goal. ​​​​Is improving scale and process efficiency enough to get to 40% gross margins, despite the structurally higher cost...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NKTR NEKTAR THERAPEUTICS
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
ACRS ACLARIS THERAPEUTICS INC.
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ORIC KEROS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
SANA VIRIDIAN THERAPEUTICS INC
PLTK SANA BIOTECHNOLOGY
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
PEPG TYRA BIOSCIENCES INC
EWTX PEPGEN INC
SLDB EDGEWISE THERAPEUTICS INC
DDI SOLID BIOSCIENCES INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B APOGEE THERAPEUTICS INC
DNTH EMBRACER GROUP AB
ORKA DIANTHUS THERAPEUTICS INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
IMA JADE BIOSCIENCES INC
IMAGENEBIO INC.
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch